Predialysis and Dialysis Therapies Differently Affect Nitric Oxide Synthetic Pathway in Red Blood Cells from Uremic Patients: Focus on Peritoneal Dialysis
Red blood cells (RBCs) have been found to synthesize and release both nitric oxide (NO) and cyclic guanosine monophosphate (cGMP), contributing to systemic NO bioavailability. These RBC functions resulted impaired in chronic kidney disease (CKD). This study aimed to evaluate whether predialysis (con...
Main Authors: | , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-03-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/6/3049 |
id |
doaj-11ee54441e4c4e46a9938b42ce4c73b6 |
---|---|
record_format |
Article |
spelling |
doaj-11ee54441e4c4e46a9938b42ce4c73b62021-03-18T00:00:24ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672021-03-01223049304910.3390/ijms22063049Predialysis and Dialysis Therapies Differently Affect Nitric Oxide Synthetic Pathway in Red Blood Cells from Uremic Patients: Focus on Peritoneal DialysisCarola Palmerini0Luca Piscitani1Giuseppina Bologna2Chiara Riganti3Paola Lanuti4Domitilla Mandatori5Lorenzo Di Liberato6Giorgia Di Fulvio7Vittorio Sirolli8Giulia Renda9Caterina Pipino10Marco Marchisio11Mario Bonomini12Assunta Pandolfi13Natalia Di Pietro14Department of Medical, Oral and Biotechnological Sciences, G. d’Annunzio University Chieti-Pescara, 66100 Chieti, ItalyNephrology and Dialysis Unit, SS. Annunziata Hospital, 66100 Chieti, ItalyCenter for Advanced Studies and Technology-CAST (ex CeSI-MeT), G. d’Annunzio University Chieti-Pescara, 66100 Chieti, ItalyDepartment of Oncology, University of Torino, 10124 Torino, ItalyCenter for Advanced Studies and Technology-CAST (ex CeSI-MeT), G. d’Annunzio University Chieti-Pescara, 66100 Chieti, ItalyDepartment of Medical, Oral and Biotechnological Sciences, G. d’Annunzio University Chieti-Pescara, 66100 Chieti, ItalyNephrology and Dialysis Unit, SS. Annunziata Hospital, 66100 Chieti, ItalyNephrology and Dialysis Unit, SS. Annunziata Hospital, 66100 Chieti, ItalyNephrology and Dialysis Unit, SS. Annunziata Hospital, 66100 Chieti, ItalyDepartment of Neuroscience, Imaging and Clinical Sciences, G. d’Annunzio University Chieti-Pescara, 66100 Chieti, ItalyDepartment of Medical, Oral and Biotechnological Sciences, G. d’Annunzio University Chieti-Pescara, 66100 Chieti, ItalyCenter for Advanced Studies and Technology-CAST (ex CeSI-MeT), G. d’Annunzio University Chieti-Pescara, 66100 Chieti, ItalyNephrology and Dialysis Unit, SS. Annunziata Hospital, 66100 Chieti, ItalyDepartment of Medical, Oral and Biotechnological Sciences, G. d’Annunzio University Chieti-Pescara, 66100 Chieti, ItalyDepartment of Medical, Oral and Biotechnological Sciences, G. d’Annunzio University Chieti-Pescara, 66100 Chieti, ItalyRed blood cells (RBCs) have been found to synthesize and release both nitric oxide (NO) and cyclic guanosine monophosphate (cGMP), contributing to systemic NO bioavailability. These RBC functions resulted impaired in chronic kidney disease (CKD). This study aimed to evaluate whether predialysis (conservative therapy, CT) and dialysis (peritoneal dialysis, PD; hemodialysis, HD) therapies used during CKD progression may differently affect NO-synthetic pathway in RBCs. Our data demonstrated that compared to PD, although endothelial-NO-synthase activation was similarly increased, HD and CT were associated to cGMP RBCs accumulation, caused by reduced activity of cGMP membrane transporter (MRP4). In parallel, plasma cGMP levels were increased by both CT and HD and they significantly decreased after hemodialysis, suggesting that this might be caused by reduced cGMP renal clearance. As conceivable, compared to healthy subjects, plasma nitrite levels were significantly reduced by HD and CT but not in patients on PD. Additionally, the increased carotid intima-media thickness (IMT) values did not reach the significance exclusively in patients on PD. Therefore, our results show that PD might better preserve the synthetic NO-pathway in CKD-erythrocytes. Whether this translates into a reduced development of uremic vascular complications requires further investigation.https://www.mdpi.com/1422-0067/22/6/3049erythrocyteschronic kidney diseasenitric oxidecGMPcardiovascular diseaseMRP4 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Carola Palmerini Luca Piscitani Giuseppina Bologna Chiara Riganti Paola Lanuti Domitilla Mandatori Lorenzo Di Liberato Giorgia Di Fulvio Vittorio Sirolli Giulia Renda Caterina Pipino Marco Marchisio Mario Bonomini Assunta Pandolfi Natalia Di Pietro |
spellingShingle |
Carola Palmerini Luca Piscitani Giuseppina Bologna Chiara Riganti Paola Lanuti Domitilla Mandatori Lorenzo Di Liberato Giorgia Di Fulvio Vittorio Sirolli Giulia Renda Caterina Pipino Marco Marchisio Mario Bonomini Assunta Pandolfi Natalia Di Pietro Predialysis and Dialysis Therapies Differently Affect Nitric Oxide Synthetic Pathway in Red Blood Cells from Uremic Patients: Focus on Peritoneal Dialysis International Journal of Molecular Sciences erythrocytes chronic kidney disease nitric oxide cGMP cardiovascular disease MRP4 |
author_facet |
Carola Palmerini Luca Piscitani Giuseppina Bologna Chiara Riganti Paola Lanuti Domitilla Mandatori Lorenzo Di Liberato Giorgia Di Fulvio Vittorio Sirolli Giulia Renda Caterina Pipino Marco Marchisio Mario Bonomini Assunta Pandolfi Natalia Di Pietro |
author_sort |
Carola Palmerini |
title |
Predialysis and Dialysis Therapies Differently Affect Nitric Oxide Synthetic Pathway in Red Blood Cells from Uremic Patients: Focus on Peritoneal Dialysis |
title_short |
Predialysis and Dialysis Therapies Differently Affect Nitric Oxide Synthetic Pathway in Red Blood Cells from Uremic Patients: Focus on Peritoneal Dialysis |
title_full |
Predialysis and Dialysis Therapies Differently Affect Nitric Oxide Synthetic Pathway in Red Blood Cells from Uremic Patients: Focus on Peritoneal Dialysis |
title_fullStr |
Predialysis and Dialysis Therapies Differently Affect Nitric Oxide Synthetic Pathway in Red Blood Cells from Uremic Patients: Focus on Peritoneal Dialysis |
title_full_unstemmed |
Predialysis and Dialysis Therapies Differently Affect Nitric Oxide Synthetic Pathway in Red Blood Cells from Uremic Patients: Focus on Peritoneal Dialysis |
title_sort |
predialysis and dialysis therapies differently affect nitric oxide synthetic pathway in red blood cells from uremic patients: focus on peritoneal dialysis |
publisher |
MDPI AG |
series |
International Journal of Molecular Sciences |
issn |
1661-6596 1422-0067 |
publishDate |
2021-03-01 |
description |
Red blood cells (RBCs) have been found to synthesize and release both nitric oxide (NO) and cyclic guanosine monophosphate (cGMP), contributing to systemic NO bioavailability. These RBC functions resulted impaired in chronic kidney disease (CKD). This study aimed to evaluate whether predialysis (conservative therapy, CT) and dialysis (peritoneal dialysis, PD; hemodialysis, HD) therapies used during CKD progression may differently affect NO-synthetic pathway in RBCs. Our data demonstrated that compared to PD, although endothelial-NO-synthase activation was similarly increased, HD and CT were associated to cGMP RBCs accumulation, caused by reduced activity of cGMP membrane transporter (MRP4). In parallel, plasma cGMP levels were increased by both CT and HD and they significantly decreased after hemodialysis, suggesting that this might be caused by reduced cGMP renal clearance. As conceivable, compared to healthy subjects, plasma nitrite levels were significantly reduced by HD and CT but not in patients on PD. Additionally, the increased carotid intima-media thickness (IMT) values did not reach the significance exclusively in patients on PD. Therefore, our results show that PD might better preserve the synthetic NO-pathway in CKD-erythrocytes. Whether this translates into a reduced development of uremic vascular complications requires further investigation. |
topic |
erythrocytes chronic kidney disease nitric oxide cGMP cardiovascular disease MRP4 |
url |
https://www.mdpi.com/1422-0067/22/6/3049 |
work_keys_str_mv |
AT carolapalmerini predialysisanddialysistherapiesdifferentlyaffectnitricoxidesyntheticpathwayinredbloodcellsfromuremicpatientsfocusonperitonealdialysis AT lucapiscitani predialysisanddialysistherapiesdifferentlyaffectnitricoxidesyntheticpathwayinredbloodcellsfromuremicpatientsfocusonperitonealdialysis AT giuseppinabologna predialysisanddialysistherapiesdifferentlyaffectnitricoxidesyntheticpathwayinredbloodcellsfromuremicpatientsfocusonperitonealdialysis AT chiarariganti predialysisanddialysistherapiesdifferentlyaffectnitricoxidesyntheticpathwayinredbloodcellsfromuremicpatientsfocusonperitonealdialysis AT paolalanuti predialysisanddialysistherapiesdifferentlyaffectnitricoxidesyntheticpathwayinredbloodcellsfromuremicpatientsfocusonperitonealdialysis AT domitillamandatori predialysisanddialysistherapiesdifferentlyaffectnitricoxidesyntheticpathwayinredbloodcellsfromuremicpatientsfocusonperitonealdialysis AT lorenzodiliberato predialysisanddialysistherapiesdifferentlyaffectnitricoxidesyntheticpathwayinredbloodcellsfromuremicpatientsfocusonperitonealdialysis AT giorgiadifulvio predialysisanddialysistherapiesdifferentlyaffectnitricoxidesyntheticpathwayinredbloodcellsfromuremicpatientsfocusonperitonealdialysis AT vittoriosirolli predialysisanddialysistherapiesdifferentlyaffectnitricoxidesyntheticpathwayinredbloodcellsfromuremicpatientsfocusonperitonealdialysis AT giuliarenda predialysisanddialysistherapiesdifferentlyaffectnitricoxidesyntheticpathwayinredbloodcellsfromuremicpatientsfocusonperitonealdialysis AT caterinapipino predialysisanddialysistherapiesdifferentlyaffectnitricoxidesyntheticpathwayinredbloodcellsfromuremicpatientsfocusonperitonealdialysis AT marcomarchisio predialysisanddialysistherapiesdifferentlyaffectnitricoxidesyntheticpathwayinredbloodcellsfromuremicpatientsfocusonperitonealdialysis AT mariobonomini predialysisanddialysistherapiesdifferentlyaffectnitricoxidesyntheticpathwayinredbloodcellsfromuremicpatientsfocusonperitonealdialysis AT assuntapandolfi predialysisanddialysistherapiesdifferentlyaffectnitricoxidesyntheticpathwayinredbloodcellsfromuremicpatientsfocusonperitonealdialysis AT nataliadipietro predialysisanddialysistherapiesdifferentlyaffectnitricoxidesyntheticpathwayinredbloodcellsfromuremicpatientsfocusonperitonealdialysis |
_version_ |
1724218032271654912 |